Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
TitlePublishedTypeProducts
Derek Nexus, The Expert System for ICH M7 - ICH M7 India RoadshowsNovember 2018pdf fileDerek Nexus
Derek Web Service 6.0 DX-XML Results FormatJanuary 2018pdf fileDerek Nexus
Derek Web Service 6.0 Installation GuideJanuary 2018pdf fileDerek Nexus
Derek Web Service 6.0 Release NotesJanuary 2018pdf fileDerek Nexus
Derek Web Service 6.0 User GuideJanuary 2018pdf fileDerek Nexus
Derek Web ServicesMay 2015pdf file
Derek Web Services 6.0 Pipeline Pilot Installation and User GuideJanuary 2018pdf fileDerek Nexus
Deriving Compound Specific Exposure Limits for Chemicals Used in Pharmaceutical SynthesisMay 2018pdf file
Determinants of Plasma Protein Binding - an in silico studySeptember 2017pdf file
Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesisMarch 2013
Developing an adverse outcome pathway framework for carcinogenicity from alerts in an expert rule-based systemSeptember 2018pdf fileDerek Nexus
Developing an adverse outcome pathway framework for carcinogenicity from alerts in an expert rule-based system.December 2018Derek Nexus
Developing AOP Networks and Making them UsefulMarch 2019pdf fileKaptis
Developing Biotransformations to Predict the Cytochrome P450 Oxidative and Reductive Dehalogenation of Haloanilines and HaloethanesJune 2011pdf fileMeteor Nexus
Developing expert in silico systemsJune 2016pdf fileDerek NexusMeteor Nexus
Developing Science within LhasaMarch 2017pdf file
Developing Structure-Activity Relationships for the Prediction of HepatotoxicityJune 2010Derek NexusMIP DILI
Development and future outlook of an in silico tool for reactivity-based purge predicitonOctober 2017pdf fileMirabilis
Development Of A Network Of Adverse Outcome Pathways (AOPs) For CarcinogenicitySeptember 2018pdf fileVitic NexusDerek NexusSarah Nexus
Development of an Adverse Outcome Pathway (AOP) Network for Carcinogenicity Using Expert-Derived (Q)SAR KnowledgeApril 2019
Development of an Adverse Outcome Pathway (AOP) Network for Carcinogenicity Using Expert-Derived (Q)SAR Knowledge. PosterMarch 2019pdf fileDerek Nexus
Development of Structure-Activity Relationships for Hepatotoxicity Using Proprietary Data.pdfApril 2010pdf fileDerek Nexus
Development of the EC3 prediction engine in DerekNovember 2015Derek Nexus
Developmental and Reproductive Toxicity Predictions in Derek NexusMarch 2017pdf fileDerek Nexus
Developments in Data SharingMarch 2017pdf file

© 2019 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.